摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(4-benzylpiperazin-1-yl)-N-[(E)-(2-methylphenyl)methylideneamino]acetamide

中文名称
——
中文别名
——
英文名称
2-(4-benzylpiperazin-1-yl)-N-[(E)-(2-methylphenyl)methylideneamino]acetamide
英文别名
——
2-(4-benzylpiperazin-1-yl)-N-[(E)-(2-methylphenyl)methylideneamino]acetamide化学式
CAS
——
化学式
C21H26N4O
mdl
——
分子量
350.5
InChiKey
JYEYXCGQXCYDAQ-PXLXIMEGSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.9
  • 重原子数:
    26
  • 可旋转键数:
    6
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    47.9
  • 氢给体数:
    1
  • 氢受体数:
    4

文献信息

  • Compositions and Methods Including Cell Death Inducers and Procaspase Activation
    申请人:HERGENROTHER Paul J.
    公开号:US20110257398A1
    公开(公告)日:2011-10-20
    Compositions and methods are disclosed in embodiments relating to induction of cell death such as in cancer cells. Compounds and related methods for synthesis and use thereof, including the use of compounds in therapy for the treatment of cancer and selective induction of apoptosis in cells are disclosed. Compounds are disclosed in connection with modification of procaspases such as procaspase-3. In embodiments, compositions are capable of activation of procaspase-3.
  • COMPOUNDS AND METHODS FOR THE TREATMENT OF CANCER
    申请人:The Board of Trustees of the University of Illinois
    公开号:US20170105989A1
    公开(公告)日:2017-04-20
    Compositions and methods are disclosed in embodiments relating to induction of cell death such as in cancer cells. Compounds and related methods for synthesis and use thereof, including the use of compounds in therapy for the treatment of cancer and selective induction of apoptosis in cells are disclosed. Compounds are disclosed in connection with modification of procaspases such as procaspase-3. In embodiments, compositions are capable of activation of procaspase-3.
  • US9522901B2
    申请人:——
    公开号:US9522901B2
    公开(公告)日:2016-12-20
查看更多